Table 1 Patient demographics
From: Prenatal ultrasound exposure and association with postnatal hearing outcomes
Dependent variable | All patients (n=100) | Pass both (n=50) | Fail at least one ear (n=50) |
|---|---|---|---|
GA birth | 255.9 (95%CI +/−43.5) | 244.66 (95%CI +/− 41.0) | 267.08 (95%CI +/−34.2) |
US 1st trimester | 0.9 (95%CI +/− 2.2) | 1.02 (95%CI +/− 2.2) | 0.82 (95%CI +/−2.1) |
US 2nd trimester | 1.84 (95%CI +/− 2.8) | 2.10 (95%CI +/− 3.4) | 1.58 (95%CI +/−1.9) |
US 3rd trimester | 5.01 (95%CI +/−7.1) | 6.66 (95%CI +/−6.1) | 3.36 (95%CI +/−6.6) |
US total | 7.77 ((95%CI +/−8.9) | 9.78 (95%CI +/− 8.1) | 5.76 (95%CI +/− 8.0) |
McNeil Sjostrom score | 2.73 (95%CI +/−) | 2.86 (95%CI +/−1.5) | 2.60 (95%CI +/− 2.1) |
ASA score | 1.38 (95%CI +/− 1.3) | 1.48 (95%CI +/− 1.4) | 1.28 (95%CI +/− 1.6) |
Maternal substance abuse | 0.14 (95%CI +/− 0.1) | 0.14 (95%CI +/− 0.7) | 0.14 (95%CI +/− 0.7) |
Perinatal hypoxia | 0.09 (95%CI +/−0.6) | 0.10 (95%CI +/-0.6) | 0.08 (95%CI +/− 0.5) |
Otologic abnormalities | none | none | none |
Familial history of hearing loss | none | none | none |
Prenatal ototoxic medication | 0.02 (95%CI +/− 0.3) | none | 0.04 (95%CI +/− 0.4) |
Postnatal ototoxic medication | 0.13 (95%CI +/− 0.7) | 0.14 (95%CI +/− 0.7) | 0.12 (95%CI +/− 0.64) |
Apgar 1 | 7.38 (95%CI +/− 3.7) | 6.84 (95%CI +/− 4.3) | 7.92 (95%CI +/− 2.6) |
Apgar 5 | 8.28 (95%CI +/− 2.7) | 7.92 (95%CI +/− 3.2) | 8.64 (95%CI +/− 2.0) |
maternal age at birth | 27.79 (95%CI +/− 13.0) | 27.94 (95%CI +/− 13.1) | 27.64 (95%CI +/− 13) |